Capturing Contrarian Views through Investment Signals
First Sentier Investors’ Co-Head of Multi-Asset Solutions Kej Somaia explains how his firm uses investment signals to spot opportunities and risks that other investors may miss.
Read MoreVideo
A Focus on the Unloved Sectors
DNR Capital Portfolio Manager Scott Kelly takes a look at the recent reporting season and focuses on some sectors that are proving attractive for income equities.
Read MoreEvening Report: ASX lifts to overcome weak jobs release
Aussie shares closed higher on Thursday despite a weaker than expected August employment release. While the ASX 200 eased from morning highs, it still added 43 points or 0.58% to 7,460.
Read MoreLunch Report: Broad improvements help lift ASX
The Aussie market is rebounding from yesterday’s falls with the ASX 200 well higher around lunch. While the disappointing August jobs numbers have weighed slightly, most sectors are higher led by materials, energy & communications.
Read MoreMorning Report: Wall St lifts as oil prices surge
The Dow Jones index rose by 237 points or 0.7%. The S&P 500 index gained 0.9%. And the Nasdaq index added 124 points or 0.8%.
Read MoreEvening Report: Down day for local shares led by energy & mining losses
The Aussie market has ended its recent winning run of three sessions after the ASX 200 fell 20pts or 0.27% to 7,417.
Read MoreLunch Report: ASX falls on banking & resources losses
At lunch, the benchmark index is down roughly 30 points but was down as much as 55 points or 0.75% at its earlier lows.
Read MoreMorning Report: US stocks ended at session lows
The Dow Jones index fell by 292 points or 0.8%. The S&P 500 index lost 0.6%. And the Nasdaq index lost 68 points or 0.5%.
Read MoreEvening Report: Aussie market gains for third straight day
The Australian sharemarket recovered from a slight fall this morning to lift for a third straight day. Energy stocks were standouts thanks to oil prices hitting six-week highs.
Read MoreIs Calima Energy the Best Way to Play the Rising Oil Price?
Calima owns a 100% interest in more than 60,000 acres of drilling and production rights in the Montney Formation (in British Columbia, Canada), one of the top ranked resource plays in North America.
Read MoreLunch Report: Aussie shares ease at midday but lift off early lows
The Australian sharemarket is down slightly on Tuesday, due partly to losses from healthcare stocks, Brambles, Fortescue and tech stocks.
Read MoreMorning Report: US & European stocks mixed as energy prices rally
The Dow Jones index rose by 262 points or 0.8% and the S&P 500 index added 10 points or 0.2%, both snapping a five-day losing streak. But the Nasdaq index lost 10 points or 0.1%.
Read MoreT. Rowe Price August 2021 Global Equity Recap
T. Rowe Price Equity Specialist Sam Ruiz gives his thoughts on how global equity markets have played out so far across sectors and around the world in the September 2021 quarter.
Read MoreEvening Report: The Aussie market recovered late to lift for a 2nd day
The Australian sharemarket recovered in the final 30 minutes of the session to finish a touch higher for a second day. Gains from resource stocks, Sydney Airport & Aristocrat Leisure helped most.
Read MoreLunch Report: Aussie stocks edge higher for second day
The Australian sharemarket is lifting for a second day, with the ASX 200 up by ~0.3%. Gains from mining and energy stocks together with Aristocrat Leisure and Sydney Airport are helping most.
Read MoreHidden Gems Webinar Recap – Perpetual, OLL, FCT, LBT & MX1
Catch up on the full webinar with a keynote presentation from Perpetual & presentations from OpenLearning (ASX: OLL), First Wave Cloud Technology (ASX: FCT), LBT Innovations (ASX: LBT) & Micro-X (ASX: MX1)
Read MoreA cloud based cybersecurity subscription model
John Grant – Executive Chairman – FirstWave Cloud Technology is an Australian-headquartered global cybersecurity company.
Read MoreMiniaturising X-Ray
Peter Rowland – Managing Director – Micro-X Ltd is an award-winning ASX listed x-ray technology company.
Read MoreDisrupting the clinical microbiology market through AI
Brent Barnes – CEO and Managing Director – LBT Innovations is a groundbreaking designer of advanced technology solutions for the medical industry.
Read MoreTargeting the $7.5b online learning market
Adam Brimo – CEO – OpenLearning is revolutionising online learning to be a social and engaging experience.
Read MoreThe investment opportunity in innovation and change
A keynote presentation on technology will be provided by Thomas Rice, Portfolio Manager for Perpetual Limited’s Global Innovation Share Fund.
Read MoreMorning Report: Wall St suffers worst week since June
The S&P 500 index lost 0.8% and the Nasdaq index fell by 133 points or 0.9%. Over the week, the Dow fell 2.2%; the S&P 500 fell 1.7%; and the Nasdaq lost 1.6%.
Read MoreEvening Report: Aussie market slumps by 1.55% this week despite Friday lift
The Australian sharemarket edged higher on Friday thanks to gains across most sectors. Unfortunately this follows the largest tumble in six and a half months on Thursday, dragging the ASX 200 lower this week.
Read MoreLunch Report: Market edges higher after worst day since February 26
The Australian sharemarket is up ~0.3% at midday after posting its biggest tumble in 6 1/2 months on Thursday. The ASX 200 is being led higher by mining stocks.
Read MoreMorning Report: US stocks lose ground for fourth session
The Dow Jones index dropped by 152 points or 0.4%. The S&P 500 index lost 0.5% and the Nasdaq index fell by 38 points or 0.3%.
Read MoreEvening Report: Largest tumble since February 26 for the Aussie market
The Australian sharemarket slumped by 1.9% on Thursday; its worst decline in months. Every sector and ~95% of stocks finished in the red.
Read MoreLunch Report: Worst tumble in 11 weeks for Aussie shares
The Australian sharemarket is down by more than 1% at midday, with banks and miners weighing most heavily on the ASX 200.
Read MoreMorning Report: Stocks retreat as investors wait for the next catalyst
US and European equity markets traded lower overnight as investors look ahead for the next significant catalyst. US sharemarkets retreated on Wednesday as investors reassessed valuations amid rising economic risks.
Read MoreEvening Report: ASX weaker led by mining & tech stocks
Aussie shares ended lower for the first time since last Thursday with the ASX 200 dropping 18 points or 0.25% to 7,512. Mining, IT & consumer staples weighed most while financials lead the improvements.
Read MoreLunch Report: ASX drops early but Macquarie rises on update
The Aussie market has again opened lower but is attempting a slight revival around lunch. The ASX 200 is down 24 points or 0.3% approaching midday with selling across most sectors.
Read MoreMorning Report: Stocks bested by sellers as rates move higher
US and European stocks generally trended lower over the course of the session overnight as investors considered the prospect of moderating growth as long term interest rates edged higher.
Read MoreEvening Report: ASX finished flat as RBA keeps rates steady
The Aussie market managed to rally late to finish flat for the day. The ASX 200 added just 1.8pts to 7,530 with miners weighing on the market.
Read MoreLunch Report: Miners & banks weigh most as ASX falls
The Aussie market is in the red by ~0.5% at lunch on Tuesday. Heavyweight miners are a major weight with the iron ore price tumbling 9% overnight while banks are also weaker ahead of the RBA September interest rate decision at 2.30pm AEST.
Read MoreMorning Report: US sharemarkets were closed on Monday
Over the week, the Dow fell by 0.2%, the S&P 500 rose by 0.6% and the Nasdaq gained 1.6%.
Read MoreLunch Report: Fortescue Metals weighs on ASX 200
The Australian sharemarket is sliding on Monday, with losses across most sectors at midday. Fortescue Metals is the main weight as it trades ex-dividend for its largest ever distribution to investors next month.
Read MoreHidden Gems Webinar Recap – CYP, AT1, NSB & KZA
Catch up on the full webinar with presentations from Cynata Therapeutics (ASX: CYP), Atomo Diagnostics (ASX: AT1), NeuroScientific (ASX: NSB) & Kazia Therapeutics (ASX: KZA).
Read MoreCell based therapeutic product platform
Dr Ross Macdonald – Managing Director and Chief Executive Officer – Cynata Therapeutics Limited is an Australian stem cell and regenerative medicine company that is developing a therapeutic stem cell platform technology.
Read MoreA high quality pipeline of cancer drugs
James Garner – Managing Director & CEO – Kazia Therapeutics Limited is an innovative oncology-focused biotechnology company. Kazia is working to develop therapies across a range of oncology indications.
Read MorePeptide based therapies for neurodegenerative conditions
Dougal Thring – VP Clinical Development – NeuroScientific Biopharmaceuticals is developing novel peptide-based pharmaceutical products that target a number of neurological disorders and diseases of the eye that have high unmet medical needs.
Read MoreRapid diagnostic testing devices
John Kelly – Founder, Managing Director & CEO – Atomo Diagnostics Limited is a global leader in the design of medical devices for blood-based rapid testing for professional use and self-testing.
Read More
